Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer

Описание к видео Dr. Nielsen on the Pros and Cons of the Ki67 Assay in Breast Cancer

Torsten O. Nielsen, MD, PhD, FRCPC, a professor of pathology at the University of British Columbia, discusses the pros and cons of using the Ki67 as a prognostic marker in breast cancer.

Комментарии

Информация по комментариям в разработке